Twenty-four months follow-up of chronic central serous chorioretinopathy patients after treatment with oral eplerenone or half-dose photodynamic therapy, and crossover treatment: SPECTRA trial report No. 4

被引：0
|
作者：
van Rijssen, Th. J. [1 ]
Feenstra, H. M. A. [1 ]
van Dijk, E. H. C. [1 ]
Tsonaka, R. [2 ]
Diederen, R. M. H. [3 ]
Hoyng, C. B. [4 ]
Schlingemann, R. O. [3 ]
Boon, C. J. F. [1 ,3 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands
[3] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands
来源：
ACTA OPHTHALMOLOGICA | 2022年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：18 / 18
页数：1
相关论文
共 48 条
  • [31] Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
    Van Rijssen, Thomas J.
    Van Dijk, Elon H. C.
    Scholz, Paula
    Breukink, Myrte B.
    Dijkman, Greet
    Peters, Petrus J. H.
    Tsonaka, Roula
    Keunen, Jan E. E.
    MacLaren, Robert E.
    Hoyng, Carel B.
    Downes, Susan M.
    Fauser, Sascha
    Boon, Camiel J. F.
    ACTA OPHTHALMOLOGICA, 2021, 99 : 34 - 35
  • [32] Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy
    van Rijssen, Thomas J.
    Singh, Sumit Randhir
    van Dijk, Elon H. C.
    Rasheed, Mohammed A.
    Vupparaboina, Kiran Kumar
    Boon, Camiel J. F.
    Chhablani, Jay
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (06) : 1191 - 1197
  • [33] Risk factors of persistent subretinal fluid after half-dose photodynamic therapy for treatment-naïve central serous chorioretinopathy
    Mengyang Li
    Jinfeng Qu
    Zhiqiao Liang
    Jiyang Tang
    Jie Hu
    Yuou Yao
    Enzhong Jin
    Xiaoxin Li
    Mingwei Zhao
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2175 - 2182
  • [34] Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial
    van Rijssen, Thomas J.
    van Dijk, Elon H. C.
    Scholz, Paula
    Breukink, Myrte B.
    Dijkman, Greet
    Peters, Petrus J. H.
    Tsonaka, Roula
    MacLaren, Robert E.
    Downes, Susan M.
    Fauser, Sascha
    Boon, Camiel J. F.
    Hoyng, Carel B.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 216 : 80 - 89
  • [35] Half-dose photodynamic therapy versus 577 nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathy
    Sitnilska, Vasilena
    Schiller, Petra
    Krohne, Tim U.
    Altay, Lebriz
    BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [36] Half-dose photodynamic therapy versus 577 nm subthreshold pulse laser therapy in treatment-naive patients with central serous chorioretinopathy
    Vasilena Sitnilska
    Petra Schiller
    Tim U. Krohne
    Lebriz Altay
    BMC Ophthalmology, 24
  • [37] 3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization
    Hu, Yu-Chen
    Chen, Yi-Ling
    Chen, Yen-Chih
    Chen, San-Ni
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] 3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization
    Yu-Chen Hu
    Yi-Ling Chen
    Yen-Chih Chen
    San-Ni Chen
    Scientific Reports, 11
  • [39] Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
    Myrte B. Breukink
    Susan M. Downes
    Giuseppe Querques
    Elon H. C. van Dijk
    Anneke I. den Hollander
    Rocio Blanco-Garavito
    Jan E. E. Keunen
    Eric H. Souied
    Robert E. MacLaren
    Carel B. Hoyng
    Sascha Fauser
    Camiel J. F. Boon
    Trials, 16
  • [40] Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
    Breukink, Myrte B.
    Downes, Susan M.
    Querques, Giuseppe
    van Dijk, Elon H. C.
    den Hollander, Anneke I.
    Blanco-Garavito, Rocio
    Keunen, Jan E. E.
    Souied, Eric H.
    MacLaren, Robert E.
    Hoyng, Carel B.
    Fauser, Sascha
    Boon, Camiel J. F.
    TRIALS, 2015, 16
12345